SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-244963
Filing Date
2021-08-13
Accepted
2021-08-12 18:32:56
Documents
15
Period of Report
2021-08-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d552481d8k.htm   iXBRL 8-K 29738
2 EX-10.1 d552481dex101.htm EX-10.1 37905
3 EX-99.1 d552481dex991.htm EX-99.1 7761
7 GRAPHIC g552481g0812140705848.jpg GRAPHIC 5164
  Complete submission text file 0001193125-21-244963.txt   220353

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cort-20210810.xsd EX-101.SCH 2888
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cort-20210810_lab.xml EX-101.LAB 17373
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cort-20210810_pre.xml EX-101.PRE 10950
8 EXTRACTED XBRL INSTANCE DOCUMENT d552481d8k_htm.xml XML 3279
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50679 | Film No.: 211169131
SIC: 2834 Pharmaceutical Preparations